MedTrace Logo

Methadone in Pediatric Anesthesia

NCT00921843 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2019-05-14

Study results available
· View outcomes & findings →

Summary

This study will determine the pharmacokinetics of intravenous (IV) methadone in children undergoing surgery.

Conditions

  • Anesthesia

Interventions

DRUG

Methadone 0.1mg/kg

Subjects will receive methadone as their intraoperative opioid.

DRUG

Methadone 0.2mg/kg

Subjects will receive methadone as their intraoperative opioid.

DRUG

Methadone 0.3mg/kg

Subjects will receive methadone as their intraoperative opioid.

DRUG

Control

Subjects will not receive methadone as their intraoperative opioid.

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Evan Kharasch, MD, PhD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00921843 on ClinicalTrials.gov